Dr. Gurleen Pasricha, MD

Dr. Pasricha practices at Meadville Medical Center in Meadville, Pennsylvania, part of Meadville Medical Center.

Dr. Pasricha's NPI, 1891041893, was assigned on July 27, 2012. Dr. Pasricha holds Pennsylvania license MD465807.

Dr. Pasricha's primary practice is Meadville Medical Center, at 751 Liberty Street, Meadville, PA 16335 in Crawford County. The practice phone is (814) 333-5000.

Dr. Pasricha's primary practice is Meadville Medical Center in Meadville, Pennsylvania, part of Meadville Medical Center. Dr. Pasricha is also affiliated with Saint Vincent Hospital. The medical group on file is Meadville Medical Center. Dmand AI also links Dr. Pasricha to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pasricha practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Pasricha's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Pasricha is licensed in Pennsylvania.

CMS data shows 826 Medicare services from Dr. Pasricha across 4 procedure codes in 2024, all of them office visits, for 185 Medicare patients. Medicare paid $64,375 for them. Every service was in an office.

CMS counts 185 Medicare patients who saw Dr. Pasricha in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pasricha's median patient age at 73, with 74% women.

In 2024, Dr. Pasricha wrote 857 Medicare Part D claims for 152 patients. 89% of them were for generic drugs. CMS names the drug for 657 of them, across 18 drugs with 11 or more claims each, at $709,245 in total drug cost. In 2023, CMS named 720 claims across 23 drugs.

Dr. Pasricha accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Pasricha in 2014. Dr. Pasricha's most frequent co-authors are Dulabh Kaur Monga, MD, Nour Daboul, MD and Aparna Kalyan, MD.

CMS Open Payments shows 274 general payments to Dr. Pasricha from 64 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Foundation Medicine, Inc. paid the most, $1,351.